CAR-T & Immunotherapy Package
What's included in this package
Medical Procedures
- Immunotherapy
- Anti TPO test
- Anti-HCVAb test
- Anti-HBC test
- Blood tests
- Biochemistry blood test
- Biopsy
- Consultation with an oncologist
- Consultation with a hematologist
- Consultation with an immunologist
- Complete blood count with cancer markers and a proteinogram
- Ultrasound
- Ultrasonography
- СT of one area
- Сonsultation with an oncohematologist
Duration
Accommodation
Accommodation is not included
Transport
Transfer is not included
Implant
No implant applicable
Additional information
This is a cutting-edge precision treatment technology for relapsed/refractory hematologic malignancies offered by the Hematologic Oncology Center. In addition to conventional PD-1/PD-L1 immune checkpoint inhibitors, the center excels in CAR-T cell therapy. The patient's own T lymphocytes are collected and genetically engineered in the laboratory to express chimeric antigen receptors (CARs), enabling them to specifically recognize and attack tumor cells. After expansion, the CAR-T cells are reinfused into the patient, triggering a powerful anti-tumor immune response. The Tongji team has extensive experience in the full-cycle management of CAR-T therapy, including early precise screening, personalized "CAR-T+X" combination strategies, and close monitoring and management of severe toxicities such as cytokine release syndrome (CRS).
What surgical procedures are included? Peripheral blood mononuclear cell (PBMC) collection (leukapheresis using a blood cell separator), CAR-T cell reinfusion.
What diagnostic procedures are included? Flow cytometry minimal residual disease (MRD) detection (for efficacy assessment), CAR-T cell expansion kinetics monitoring, contrast-enhanced brain MRI (for neurotoxicity prevention), whole-body imaging evaluation.
Are there any implants? No.
24/7 Bookimed assistance
- Personal medical coordinator
- Medical travel arrangements — booking of air tickets and hotel rooms at special partner prices
- Patient advocacy during medical travel
Program price
What's NOT included in this package
Doctor
Dr. Li Ping, M.D., Ph.D., is Chief Physician and Professor in the Department of Hematology at Shanghai Tongji Hospital, Tongji University School of Medicine. She supervises doctoral and master's students and is an expert in hematologic malignancies.
She earned a Doctor of Medical Science from Nagoya University and completed postdoctoral research. She specializes in diagnosing and treating blood cancers. Her focus includes lymphoid malignancies—leukemias, lymphomas, and multiple myeloma. She treats patients with chemotherapy, hematopoietic stem cell transplantation, targeted therapy, and immunotherapy.
She is a pioneer in China in full-cycle CAR-T therapy for relapsed or refractory blood cancers. She leads and participates in national and international clinical trials. She serves on committees of professional societies, including the China Anti-Cancer Association. She also publishes and trains hematologists.
How are we doing?
About the clinic
CAR-T cell therapy at Shanghai Tongji Hospital in China is a specialized immunotherapy for patients with blood cancers. This treatment uses the body's own immune cells to find and fight cancer. The hospital is known for its hematology department and its status as a tertiary university-affiliated facility.
Advanced CAR-T Cell Therapy Program
The CAR-T program at this clinic started in 2014. Since then, the medical team has performed over 1,500 infusions. This high number shows the clinic has significant experience with cell therapy. The program focuses on treating lymphoma and other blood-related cancers that do not respond to standard care.
Success Rates and Treatment Options
The hospital reports strong results for patients undergoing this therapy. In lymphoma cases, about 87% of patients reach complete remission within three months. Doctors here do not just use standard methods. They also offer combination therapies for high-risk cases and epigenetic immunotherapy for patients with multi-resistant cancer. The team also works on next-generation CAR-NK treatments, with research published in top journals like Nature Cancer.
The Treatment Process
Before therapy begins, patients undergo a detailed screening process. This includes immunophenotyping to check if CAR-T will work for them. Doctors also use biopsies and imaging-guided assessments to plan the care. The hospital follows a standardized treatment pathway to help with patient safety.
Care continues long after the infusion is finished. A multidisciplinary tumor board meets to review each case. This board includes experts in these fields:
- Hematology to manage the blood cancer treatment
- Radiology and Pathology for precise monitoring
- Nutrition and Psychological support to help with recovery
Patients seeking advanced options for refractory blood cancers can request a consultation through Bookimed to learn about eligibility for these programs.
Payment & Rewards
You don’t pay for our services
You make your payment directly at the clinic or to their official bank account.
Some clinics may require a deposit as a part of their policy.
Spread out your payments with installment options.
Earn rewards for referring friends to Bookimed.